Bank of New York Mellon’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
888,466
+24,827
| +3% | +$30.8K | ﹤0.01% | 3068 |
|
|
2025
Q1 | $1.02M | Sell |
863,639
-4,340,328
| -83% | -$5.12M | ﹤0.01% | 3044 |
|
|
2024
Q4 | $9.52M | Sell |
5,203,967
-369,200
| -7% | -$676K | ﹤0.01% | 1944 |
|
|
2024
Q3 | $9.47M | Sell |
5,573,167
-4,362,004
| -44% | -$7.42M | ﹤0.01% | 1960 |
|
|
2024
Q2 | $13.6M | Sell |
9,935,171
-1,440,228
| -13% | -$1.97M | ﹤0.01% | 1800 |
|
|
2024
Q1 | $42.7M | Buy |
11,375,399
+6,482,961
| +133% | +$24.3M | 0.01% | 1126 |
|
|
2023
Q4 | $48M | Buy |
4,892,438
+489,639
| +11% | +$4.8M | 0.01% | 1066 |
|
|
2023
Q3 | $36.8M | Buy |
4,402,799
+2,514,656
| +133% | +$21M | 0.01% | 1178 |
|
|
2023
Q2 | $25.1M | Buy |
1,888,143
+393,237
| +26% | +$5.23M | 0.01% | 1424 |
|
|
2023
Q1 | $17.3M | Buy |
1,494,906
+530,864
| +55% | +$6.15M | ﹤0.01% | 1625 |
|
|
2022
Q4 | $7.89M | Buy |
964,042
+1,652
| +0.2% | +$13.5K | ﹤0.01% | 2055 |
|
|
2022
Q3 | $5.59M | Buy |
962,390
+115,158
| +14% | +$669K | ﹤0.01% | 2238 |
|
|
2022
Q2 | $3.75M | Sell |
847,232
-149,812
| -15% | -$662K | ﹤0.01% | 2477 |
|
|
2022
Q1 | $9.07M | Sell |
997,044
-9,695
| -1% | -$88.2K | ﹤0.01% | 2116 |
|
|
2021
Q4 | $20.6M | Buy |
1,006,739
+11,720
| +1% | +$240K | ﹤0.01% | 1709 |
|
|
2021
Q3 | $25.4M | Buy |
995,019
+41,230
| +4% | +$1.05M | 0.01% | 1583 |
|
|
2021
Q2 | $33.4M | Sell |
953,789
-9,242
| -1% | -$323K | 0.01% | 1433 |
|
|
2021
Q1 | $32.1M | Sell |
963,031
-41,989
| -4% | -$1.4M | 0.01% | 1420 |
|
|
2020
Q4 | $26.1M | Sell |
1,005,020
-17,838
| -2% | -$463K | 0.01% | 1476 |
|
|
2020
Q3 | $10.1M | Buy |
1,022,858
+1,295
| +0.1% | +$12.8K | ﹤0.01% | 1848 |
|
|
2020
Q2 | $3.52M | Sell |
1,021,563
-47,611
| -4% | -$164K | ﹤0.01% | 2380 |
|
|
2020
Q1 | $3.27M | Buy |
1,069,174
+858
| +0.1% | +$2.63K | ﹤0.01% | 2289 |
|
|
2019
Q4 | $5.49M | Sell |
1,068,316
-40,068
| -4% | -$206K | ﹤0.01% | 2295 |
|
|
2019
Q3 | $5.72M | Buy |
1,108,384
+454,281
| +69% | +$2.34M | ﹤0.01% | 2213 |
|
|
2019
Q2 | $3.96M | Buy |
654,103
+12,014
| +2% | +$72.7K | ﹤0.01% | 2449 |
|
|
2019
Q1 | $4.64M | Buy |
642,089
+21,788
| +4% | +$158K | ﹤0.01% | 2366 |
|
|
2018
Q4 | $4.59M | Buy |
620,301
+74,002
| +14% | +$548K | ﹤0.01% | 2346 |
|
|
2018
Q3 | $2.96M | Buy |
546,299
+58,409
| +12% | +$316K | ﹤0.01% | 2644 |
|
|
2018
Q2 | $1.73M | Buy |
487,890
+50,699
| +12% | +$180K | ﹤0.01% | 2939 |
|
|
2018
Q1 | $897K | Buy |
437,191
+18,785
| +4% | +$38.5K | ﹤0.01% | 3276 |
|
|
2017
Q4 | $1.11M | Sell |
418,406
-41,152
| -9% | -$109K | ﹤0.01% | 3179 |
|
|
2017
Q3 | $2.41M | Buy |
459,558
+86,415
| +23% | +$454K | ﹤0.01% | 2729 |
|
|
2017
Q2 | $1.33M | Sell |
373,143
-34,755
| -9% | -$124K | ﹤0.01% | 3086 |
|
|
2017
Q1 | $2.11M | Buy |
407,898
+17,794
| +5% | +$92K | ﹤0.01% | 2818 |
|
|
2016
Q4 | $1.48M | Buy |
390,104
+25,199
| +7% | +$95.7K | ﹤0.01% | 3040 |
|
|
2016
Q3 | $3.27M | Buy |
364,905
+6,015
| +2% | +$53.9K | ﹤0.01% | 2453 |
|
|
2016
Q2 | $2.53M | Buy |
358,890
+26,823
| +8% | +$189K | ﹤0.01% | 2582 |
|
|
2016
Q1 | $2.82M | Buy |
332,067
+10,179
| +3% | +$86.5K | ﹤0.01% | 2461 |
|
|
2015
Q4 | $4.23M | Sell |
321,888
-12,217
| -4% | -$160K | ﹤0.01% | 2317 |
|
|
2015
Q3 | $1.22M | Sell |
334,105
-57,279
| -15% | -$210K | ﹤0.01% | 3043 |
|
|
2015
Q2 | $2.25M | Buy |
391,384
+40,460
| +12% | +$233K | ﹤0.01% | 2831 |
|
|
2015
Q1 | $2.05M | Buy |
350,924
+19,424
| +6% | +$113K | ﹤0.01% | 2845 |
|
|
2014
Q4 | $2.6M | Buy |
331,500
+45,677
| +16% | +$358K | ﹤0.01% | 2687 |
|
|
2014
Q3 | $1.4M | Buy |
285,823
+1,611
| +0.6% | +$7.91K | ﹤0.01% | 3096 |
|
|
2014
Q2 | $1.76M | Buy |
284,212
+65,331
| +30% | +$404K | ﹤0.01% | 2978 |
|
|
2014
Q1 | $1.17M | Sell |
218,881
-15,147
| -6% | -$81K | ﹤0.01% | 3192 |
|
|
2013
Q4 | $1.22M | Buy |
234,028
+16,113
| +7% | +$84.3K | ﹤0.01% | 3178 |
|
|
2013
Q3 | $1.2M | Sell |
217,915
-889
| -0.4% | -$4.91K | ﹤0.01% | 3132 |
|
|
2013
Q2 | $554K | Buy |
+218,804
| New | +$554K | ﹤0.01% | 3455 |
|